Reading this on a mobile device? Try our optimized mobile version here:

December 7, 2012News for the transfusion medicine and cellular therapy community

  Top Story 
  • Discovery could protect blood stem cells during sepsis, chemo
    Australian researchers have pinpointed a "kill switch" that eliminates blood stem cells during stress brought on by events such as chemotherapy or sepsis, according to a study in the journal Immunity. "You have to repopulate those immune cells somehow and these come from progenitor cells in the bone marrow and we think that this cell death pathway is something we can block to try and help the new cells regenerate to fight the infections better," said researcher Dr. Seth Masters. ABC (Australia)/"AM With Tony Eastley" (12/7) LinkedInFacebookTwitterEmail this Story
The NEWEST innovation in Transfusion Software from Mediware®
Be the first to experience HCLL 2012. The sleek, web-based platform offers new dashboards, dynamic navigation, and simple solutions to meet the growing needs of hospital blood banks while providing the ultimate in control and efficiency for patient safety. Learn more about the newest blood management solution from Mediware.

  Science & Health 
  • Héma-Québec to conduct more tests on quarantined blood
    Héma-Québec is continuing its quarantine on certain blood and has received approval from Health Canada to perform additional tests for bacteria. So far, the tests have not found bacteria and health officials have not reported infections in patients. The quarantine began after microfissures were found in blood-collection devices. A total of 15 devices have now been identified as having the leaks, Héma-Québec said. Haemonetics has responded to this issue and has included information for its customers on its website. The Gazette (Montreal) (tiered subscription model) (12/5) LinkedInFacebookTwitterEmail this Story
  Emerging Trends 
  Industry News & Practice 
  • Curetis plans 2014 FDA filing for Unyvero System
    Curetis said it plans to file a 510(k) submission to the FDA for its Unyvero System in 2014. The test employs polymerase chain reaction technology to isolate, amplify and identify DNA for bacteria and antibiotic resistance. To prepare for the filing, the company has initiated a clinical trial for the system and its lower respiratory tract application. The company is working on a second Unyvero application for implant and tissue infections, and on cartridges for conditions including bloodstream infections. GenomeWeb Daily News (free registration) (12/6) LinkedInFacebookTwitterEmail this Story

Digi-Trax® Corporation Helps Ensure your Facility's FDA Compliance
HemaTrax-UNITY is our newest blood bank software for printing ISBT 128 compliant labels. It works with your BBIS and can also be used as a standalone system — very useful for disaster recovery. Our single-source solution combines HemaTrax-UNITY software with printers, scanners, validation, labels and service. Learn more.

  Government & Regulatory 
  • FDA approves more drugs this year
    The FDA has approved 31 new drugs in 2012 for conditions including cancer, HIV, multiple sclerosis and rheumatoid arthritis. The total is the most since 2004, reflecting faster drug development. A separate report showed that in fiscal year 2012 the agency granted 35 new approvals. The Wall Street Journal (12/5) LinkedInFacebookTwitterEmail this Story
  • 2 lawmakers unveil bill requiring FDA registration of compounders
    Reps. Rosa DeLauro, D-Conn., and Nita Lowey, D-N.Y., introduced legislation that would mandate registration with the FDA by drug compounders. The Supporting Access to Formulated and Effective Compounded Drugs Act would create an FDA database for use by federal and state regulators in the oversight of compounding pharmacies, but the bill is not expected to be voted on by the end of this session. On Dec. 19, state and FDA officials will meet to discuss states' current authority to regulate compounders. Modern Healthcare (subscription required) (12/5), Reuters (12/5) LinkedInFacebookTwitterEmail this Story
  • Governors urge Obama to loosen strings on Medicaid funds
    Governors meeting with President Barack Obama about avoiding automatic tax increases and spending cuts asked for more flexibility in their management of Medicaid and other federal-state programs. Delaware Gov. Jack Markell, a Democrat, said that his state would have to revisit its plan to expand Medicaid eligibility under the Affordable Care Act if the federal government reduces funding. CBS News (12/4) LinkedInFacebookTwitterEmail this Story
  Association News 
  • AABB seeks next CEO
    AABB seeks a leader with a commitment to improving health care to serve as its next chief executive officer. This prestigious position offers an extraordinary opportunity to lead a respected national professional and scientific association that serves as a preeminent knowledge-based organization focused on improving health through advancing the science and practice of transfusion medicine and cellular therapies. The executive search firm Witt/Kieffer has been retained by AABB to assist in recruiting the new CEO. Those interested in applying for the position should visit the company's website for more details. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
West Coast Account ManagerMacopharma USAUS - Nationwide
Director, Patient Blood ManagementAABBUS - MD - Bethesda
Click here to view more job listings.

You will never find time for anything. If you want time you must make it."
--Charles Buxton,
British brewer, philanthropist, writer and legislator

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
A powerful website for SmartBrief readers including:
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Cristian Becker

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information